Observations made by our group during clamping of plasma glucose at different glycemic levels, seem to indicate that the glucagonotropic action of GIP in type 2 diabetes is preserved during periods of hypoglycemia and/or euglycemia [110]. The gene discussed is GIP; the disease is type 2 diabetes mellitus.